Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1996-10-16
pubmed:abstractText
BACKGROUND AND METHODS: By multivariable analysis, risk factors were identified for initial infection of any type, cumulative infections during the first 6 months and fatal infection among 2210 heart transplant recipients at 30 institutions. RESULTS AND CONCLUSIONS: Of the 1218 infections in 695 patients, bacterial infections were most frequent (47%), followed by viral (42%), fungal (8%), and protozoal (4%). Risk factors for earlier infection included older recipient age (p < 0.0001), ventilator support at time of transplant (p < 0.0001), ventricular assist device at time of transplant (p = 0.02), OKT3 induction therapy (p < 0.0001), donor black race (p = 0.0007), and positive donor cytomegalovirus serology (for cytomegalovirus infection) (p = 0.0007). Cumulative infections during the first 6 months were increased by older recipient age (p < 0.0001), ventilator support at transplant (p = 0.0004), ventricular assist at transplant (p = 0.009), Black donor (p = 0.03), female donor (p = 0.03), and OKT3 induction therapy (p = 0.005). The actuarial freedom from fatal infection was 96% at 1 year and 95% at 3 years. Risk factors for death from infection included very old (p = 0.002) and very young recipients (p = 0.004), ventilator support at time of transplant (p = 0.004), older donor (p < 0.0001), and longer donor ischemic time (p = 0.02). The risk of death from infection within the first 3 months exceeded 20% among older recipients (> 55 years) on ventilator support at time of transplantation who received an older (> 50 years) donor heart.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
329-41
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8732591-Actuarial Analysis, pubmed-meshheading:8732591-African Americans, pubmed-meshheading:8732591-Age Factors, pubmed-meshheading:8732591-Bacterial Infections, pubmed-meshheading:8732591-Female, pubmed-meshheading:8732591-Heart Transplantation, pubmed-meshheading:8732591-Heart-Assist Devices, pubmed-meshheading:8732591-Humans, pubmed-meshheading:8732591-Immunosuppressive Agents, pubmed-meshheading:8732591-Male, pubmed-meshheading:8732591-Middle Aged, pubmed-meshheading:8732591-Muromonab-CD3, pubmed-meshheading:8732591-Mycoses, pubmed-meshheading:8732591-Postoperative Complications, pubmed-meshheading:8732591-Protozoan Infections, pubmed-meshheading:8732591-Respiration, Artificial, pubmed-meshheading:8732591-Risk Factors, pubmed-meshheading:8732591-Sex Factors, pubmed-meshheading:8732591-Time Factors, pubmed-meshheading:8732591-Tissue Donors, pubmed-meshheading:8732591-Virus Diseases
pubmed:year
1996
pubmed:articleTitle
Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study.
pubmed:affiliation
Cardiac Transplant Research Database Group, University of Alabama at Birmingham, USA.
pubmed:publicationType
Journal Article, Multicenter Study